UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052793
Receipt number R000060181
Scientific Title An exploratory study to identify the factors related to recurrence of Generalized Pustular Psoriasis (GPP) flare in adult patients with GPP in Japan
Date of disclosure of the study information 2023/11/22
Last modified on 2023/11/13 09:59:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory study to identify the factors related to recurrence of Generalized Pustular Psoriasis (GPP) flare in adult patients with GPP in Japan

Acronym

An exploratory study to identify the factors related to recurrence of GPP flare

Scientific Title

An exploratory study to identify the factors related to recurrence of Generalized Pustular Psoriasis (GPP) flare in adult patients with GPP in Japan

Scientific Title:Acronym

An exploratory study to identify the factors related to recurrence of GPP flare

Region

Japan


Condition

Condition

Generalized Pustular Psoriasis (GPP)

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Are there any factors related to recurrence of Generalized Pustular Psoriasis (GPP) flares?

Basic objectives2

Others

Basic objectives -Others

This study will explore the factors related to recurrence of GPP flares, such as patient background, the severity of the baseline GPP flare, types of treatment, or infections, in patients with GPP.

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Outcome: Recurrence of GPP flares in patients who experienced a GPP flare at baseline
Time Frame: From the date of onset of the baseline GPP flare to the date of recurrence of a GPP flare or to the end of the follow-up
Event: Recurrence of GPP flares confirmed by the Data Review Committee

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

-Patients who have been diagnosed with von Zumbusch type of GPP
-Patients who experienced a GPP flare at baseline confirmed by the Data Review Committee
-Patients whose data were properly obtained for this study in accordance with the local regulations

Key exclusion criteria

-Patients who have been diagnosed with paediatric GPP, impetigo herpetiformis, or other categories of GPP
-Patients who have been diagnosed with unknown disease categories of GPP

Target sample size

205


Research contact person

Name of lead principal investigator

1st name Reina
Middle name
Last name Mizuno

Organization

Nippon Boehringer Ingelheim Co., Ltd.

Division name

Medical Affairs Group, TA-Immunology, Special Care Medicine, Medicine.Div.

Zip code

141-6017

Address

ThinkPark Tower, 2-1-1, Osaki, Shinagawa-ku, Tokyo

TEL

03-6417-2200

Email

reina.mizuno@boehringer-ingelheim.com


Public contact

Name of contact person

1st name Reina
Middle name
Last name Mizuno

Organization

Nippon Boehringer Ingelheim Co., Ltd.

Division name

Medical Affairs Group, TA-Immunology, Special Care Medicine, Medicine.Div.

Zip code

141-6017

Address

ThinkPark Tower, 2-1-1, Osaki, Shinagawa-ku, Tokyo

TEL

03-6417-2200

Homepage URL


Email

reina.mizuno@boehringer-ingelheim.com


Sponsor or person

Institute

Nippon Boehringer Ingelheim Co., Ltd.

Institute

Department

Personal name

Reina Mizuno


Funding Source

Organization

Nippon Boehringer Ingelheim Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Takahashi Clinic Ethics Committee

Address

Medicalhat 1F, 5-1-31, Iwaya-kitamachi, Nada-ku, Kobe-shi, Hyogo

Tel

078-882-6432

Email

kishimoto.satoshi@neues.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 11 Month 02 Day

Date of IRB

2023 Year 11 Month 08 Day

Anticipated trial start date

2023 Year 11 Month 22 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study will be conducted through secondary use of the existing data (UMIN ID: UMIN000042865; Study Title: A study on the treatments and flare frequency of patients with GPP in Japan, and human genome and genetic analysis to research for genetic mutations: Assessment of treatments, flare frequency and research for novel genetic mutations involved in the pathogenesis of GPP).


Management information

Registered date

2023 Year 11 Month 14 Day

Last modified on

2023 Year 11 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060181


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name